SecSonar.com

XOMA Royalty Corp. (XOMA)

XOMA Royalty Corp. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

XOMA Royalty Corp. (XOMA) is a Biotechnology company based in US with a market capitalization of $523.3M. Revenue grew 83.1% year-over-year and the company generated $2.9M in free cash flow. This page tracks XOMA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 13 employees · IPO Jun 6, 1986

Valuation

Valuation & price

$41.75 · as of May 17, 2026 · -2.9% vs 52w high

23.7

P/E ratio

Latest-FY diluted EPS

5.03

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$43.00$33.13$23.27Jul 25Dec 25Jul 26Jul 7, 25$26.17Jul 9, 25$27.71Jul 11, 25$27.14Jul 15, 25$26.26Jul 17, 25$26.30Jul 21, 25$25.48Jul 23, 25$25.93Jul 25, 25$25.83Jul 29, 25$26.47Jul 31, 25$24.88Aug 4, 25$27.25Aug 6, 25$26.42Aug 11, 25$27.23Aug 13, 25$30.89Aug 15, 25$31.37Aug 19, 25$32.06Aug 21, 25$32.75Aug 25, 25$33.77Aug 27, 25$33.68Aug 29, 25$32.47Sep 3, 25$34.86Sep 5, 25$35.24Sep 9, 25$36.76Sep 11, 25$37.72Sep 16, 25$37.09Sep 18, 25$37.59Sep 22, 25$37.16Sep 24, 25$36.78Sep 26, 25$36.68Sep 30, 25$38.54Oct 2, 25$39.54Oct 6, 25$36.61Oct 8, 25$36.35Oct 10, 25$36.43Oct 14, 25$37.01Oct 16, 25$36.49Oct 21, 25$34.81Oct 23, 25$34.27Oct 27, 25$34.91Oct 29, 25$33.35Oct 31, 25$32.98Nov 4, 25$32.49Nov 6, 25$34.07Nov 10, 25$33.49Nov 12, 25$33.62Nov 14, 25$32.64Nov 18, 25$32.79Nov 20, 25$31.83Nov 25, 25$31.85Nov 28, 25$32.13Dec 2, 25$29.76Dec 4, 25$31.13Dec 8, 25$30.49Dec 10, 25$34.36Dec 12, 25$25.22Dec 16, 25$25.83Dec 18, 25$24.90Dec 22, 25$25.58Dec 24, 25$25.99Dec 29, 25$25.25Jan 2, 26$27.99Jan 6, 26$26.45Jan 8, 26$29.92Jan 12, 26$26.79Jan 14, 26$29.36Jan 16, 26$26.37Jan 21, 26$27.27Jan 23, 26$26.70Jan 27, 26$25.71Jan 29, 26$24.97Feb 2, 26$26.47Feb 4, 26$26.91Feb 9, 26$23.65Feb 11, 26$23.27Feb 13, 26$24.01Feb 18, 26$24.35Feb 20, 26$25.81Feb 24, 26$27.04Feb 26, 26$26.76Mar 2, 26$26.21Mar 4, 26$26.45Mar 6, 26$25.98Mar 10, 26$27.28Mar 12, 26$26.86Mar 17, 26$27.00Mar 19, 26$28.76Mar 23, 26$29.77Mar 25, 26$30.20Mar 27, 26$30.17Mar 31, 26$31.37Apr 2, 26$32.98Apr 7, 26$34.58Apr 9, 26$36.76Apr 13, 26$38.65Apr 15, 26$40.13Apr 17, 26$39.71Apr 22, 26$39.37Apr 24, 26$37.90Apr 28, 26$40.86Apr 30, 26$40.94May 4, 26$41.04May 6, 26$41.60May 8, 26$41.89May 12, 26$41.75May 14, 26$42.00May 18, 26$41.64May 20, 26$41.98May 22, 26$41.65May 28, 26$41.70Jun 1, 26$41.69Jun 3, 26$41.70Jun 5, 26$42.09Jun 9, 26$41.95Jun 11, 26$41.80Jun 15, 26$41.95Jun 17, 26$41.72Jun 22, 26$42.00Jun 24, 26$42.15Jun 26, 26$42.15Jul 2, 26$43.00
$22.8952-week range$43.00
Loading valuation history…

Fundamentals

Key fundamentals

$523.3M

Market cap

83.1%

Revenue growth (YoY)

94.3%

Gross margin

$2.9M

Free cash flow (USD)

$48.6M

Net debt

53.7%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$5.6MFY 2017$52.7MFY 2018$5.3MFY 2019$18.4MFY 2020$29.4MFY 2021$38.2MFY 2022$6.0MFY 2023$4.8MFY 2024$28.5MFY 2025$52.1M
$5.6M$52.1M

Free cash flow by year

2016 → 2025

FY 2016$-33.7MFY 2017$2.7MFY 2018$-27.6MFY 2019$-19.6MFY 2020$8.9MFY 2021$-3.8MFY 2022$-28.1MFY 2023$-18.2MFY 2024$-13.8MFY 2025$2.9M
-$33.7M$2.9M

Gross margin by year

2021 → 2025

FY 202199.5%FY 202295.5%FY 202397.0%FY 202499.3%FY 202594.3%
99.5%94.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAcquisition UpdateJun 12, 2026Filing
  • 8-K eventIncentive Plan AmendmentMay 22, 2026Filing
  • 8-K eventMerger Agreement AmendmentMay 18, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • 8-K eventMerger AgreementApr 27, 2026Filing
  • 8-K eventAcquisition CompletedApr 27, 2026Filing

Questions

Frequently asked questions

What is XOMA Royalty Corp.'s market cap?

XOMA Royalty Corp. (XOMA) has a market capitalization of $523.3M.

What is XOMA's P/E ratio?

XOMA trades at a price-to-earnings ratio of 23.7, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is XOMA's price-to-book (P/B) ratio?

XOMA trades at 5.03 times book value per share.

Are insiders buying XOMA stock?

SEC Form 4 filings show no open-market insider buys at XOMA Royalty Corp. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ALLO

Allogene Therapeutics, Inc.

$524.6M

PRTA

Prothena Corporation plc

$528.8M

FDMT

4D Molecular Therapeutics, Inc.

$506.6M

ACRS

Aclaris Therapeutics, Inc.

$546.3M

CTNM

Contineum Therapeutics, Inc. Class A Common Stock

$499.1M

MDXG

MiMedx Group, Inc.

$553.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.